Patient-Derived Treatment Options
Autologous Cellular Therapy
Our cellular protocols use material collected from bone marrow at the iliac crest of the pelvis or from adipose tissue in the abdomen or buttocks. These tissues contain mixed cellular populations, including stromal cells involved in normal tissue maintenance.
Collected material is processed onsite, with centrifugation used where appropriate to prepare it for same-day administration. The resulting preparation is not necessarily a purified or expanded mesenchymal stem cell product.
Selected protocols also incorporate red low-level laser delivery at the collection site before harvesting. We explain its proposed role separately, as improved cellular vitality or treatment outcomes from this addition have not been established.
Conditions evaluated may include osteoarthritis of the knees, hips, shoulders, and ankles, as well as selected degenerative spine conditions, disc-related symptoms, and persistent pain following spinal fusion. Suitability depends on the diagnosis, tissue preparation, and regulatory requirements.
Platelet-Rich Plasma Therapy
PRP begins with a blood draw, which is processed to concentrate platelets and associated signaling factors. We use ultrasound to guide placement into selected areas according to the diagnosis and treatment plan.
PRP may be considered for certain tendon disorders and osteoarthritis. Meniscal, labral, and other structural injuries require individual assessment, as an injection does not necessarily close a tear or restore damaged cartilage.
SuperShot® PRP
SuperShot® is our enhanced PRP protocol, designed to retain and incorporate additional plasma-derived components, including extracellular vesicles carrying signaling molecules such as microRNAs.
These components are involved in cellular communication. We discuss the preparation and its intended role without assuming that their inclusion produces faster healing or superior outcomes compared with standard PRP.
Autologous Intraosseous Therapy
Intraosseous Restorative Therapy, also called bone marrow decompression within our protocols, involves accessing selected subchondral bone—the bone beneath joint cartilage.
A small amount of marrow blood is aspirated and, in the described OWM protocol, combined with medical ozone and selected solutions before reinjection. The proposed aim is to address pressure and local circulation within the bone. Evidence for this approach, including restoration of cartilage nutrition or structural repair, requires separate consideration.
Supporting Protocols
Three-Day Preconditioning IV Package
Selected cellular treatment plans include a series of nutrient and oxygen/ozone-based infusions before harvesting and injection. We review the contents, intended purpose, and risks individually, recognizing that improved cell survival or engraftment from this preparation has not been established.
Peptide Preparations
Our protocols may include discussion of CJC-1295 and ipamorelin before treatment, or BPC-157 and thymosin beta-4 within proposed injection preparations. These require specific review of evidence, product quality, and regulatory status rather than being presented as established methods of enhancing regeneration.
Comprehensive Structural Assessment
Our approach considers the joint capsule, surrounding ligaments, and supporting tendons alongside the joint itself. Hackett-Hemwall principles may inform treatment of selected supporting structures, with injection sites determined by examination and imaging.
Weber Endo Laser Photobiomodulation
Selected plans may incorporate interstitial fiberoptic light delivery near the treatment area. Wavelengths described within our protocols include red, blue, yellow, and infrared.
We explain the proposed application and available evidence separately, as activation of injected platelets or growth factors and improved recovery from these combinations are not assured.
High-Resolution Ultrasound Guidance
We use ultrasound to visualize relevant anatomy and guide needle placement where appropriate during collection and injection. Imaging supports precision, while each procedure still requires careful technique and carries potential risks.
Assessment, Recovery & Safety
Your consultation includes a review of symptoms, medical history, previous procedures, and relevant imaging. We explain the proposed tissue source, preparation, treatment sites, alternatives, and recovery requirements before proceeding.
Using your own material reduces concerns about donor incompatibility but does not eliminate adverse reactions or procedural complications. Risks may include soreness, bruising, bleeding, infection, and injury to nearby structures.
Follow-up focuses on pain, movement, and daily function, with rehabilitation and activity guidance incorporated when appropriate. Patient-derived cellular procedures should not be described as FDA-approved stem cell treatments for orthopedic conditions or as guaranteed methods of cartilage regeneration.
